Skip to content
Source: LibraryDue February 5, 2026

Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)

by HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)

Deadline
February 5, 2026
Award Amount
Varies
Eligibility
See details

About this opportunity

Full details for this opportunity are available on the official funder website. View the official posting for complete information about eligibility, requirements, and how to apply.

Verified Information

  • Documentation available
  • Deadline confirmed
  • Secure connection
Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) | Funding Landscape | Funding Landscape